Skip to navigation Skip to main content Skip to footer

Updates

SUB-TYPE:

Scotland - World Cup Bank Holiday Openings Hours

To help keep our customers informed of changes to our service, we have published our 2026 World Cup bank holiday opening hours for pharmacy and retail customers in Scotland:

 

Scotland World Cup bank holiday opening hours

SUB-TYPE: CLASS 3 RECALL

Class 3 recall-Napralief 9s

Omega Pharma Ltd is recalling specific batches of Napralief 250mg Gastro-Resistant Tablets due to missing text in Section 2 and Section 3 of the Patient Information Leaflet (PIL) and on the Carton in packs of Napralief 250mg Gastro-resistant tablets.

 

MHRA drug alert link: Class 3 Medicines Recall: Omega Pharma Ltd, Napralief 250mg Gastro-Resistant Tablets, EL(26)A/21 - GOV.UK

 

MHRA drug alert date:23/04/26

 

Pip code

Product description

Supplier

Batch Numbers

4365961

NAPRALIEF 9S

 OMEGA PHARMA LIMITED

B51496
B51497
B51102

 

 

Further Information

For all medical information enquiries, stock control queries and information on this product, please email UKLOcustomerservice@perrigo.com or call +44 0203 598 9603.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

 

 

 

 

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 caution in use-PI Hiprex 1g tablets

Doncaster Pharma Limited has informed the MHRA of an error related to the Braille embossing on the outer packaging of certain parallel imported batches of Hiprex 1 g tablets (POM).

 

MHRA drug alert Date: 26/3/26

 

MHRA drug alert link: Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex 1g tablets, EL(26)A/20 - GOV.UK

 

Pip code

Product description

Supplier

Batch Numbers

8062713

PI HIPREX TAB 1G

Doncaster Pharma Limited

251352/BA
251358/BA
252137/BA
252137/BB
251358/BB

 

This is a caution in use only we are not accepting stock returns

 

Further Information

 

For all medical information enquiries and information on this product, please email regulatory@doncasterpharma.co.uk or quality.enquiries@doncasterpharma.co.uk, or telephone 01302 365 000.

For stock control enquiries, please email commercial@doncasterpharma.co.uk, or telephone 01302 365 000.

SUB-TYPE: CLASS 2 RECALL

Class 2 recall-Ramipril 10mg Caps

Crescent Pharma Limited is recalling one batch of Ramipril 10mg Capsules as a precautionary measure due to a potential error at the manufacturing site.

 

MHRA drug alert link: Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 10mg capsules, EL(26)A/19 - GOV.UK

 

MHRA drug alert date:20/04/26

 

Pip code

Product description

Supplier

Batch Numbers

1117878

RAMIPRIL CAP 10MG ALM

Crescent Pharma

GR174091

1112606

RAMIPRIL CAP 10MG ACC

Crescent Pharma

GR174091

1276070

RAMIPRIL CAP 10MG SDZ

Crescent Pharma

GR174091

1111541

RAMIPRIL CAP 10MG TEV

Crescent Pharma

GR174091

1219500

RAMIPRIL CAP 10MG WCK

Crescent Pharma

GR174091

 

 

Further Information

For all medical information enquiries and information, please email medinfo@crescentpharma.com, for reporting of side effects email safety@crescentpharma.com or telephone +44 1217901596 and for stock control enquiries please email complaints@crescentpharma.com

SUB-TYPE:

Alphega join Pharmacy Planet podcast

In Spring 26, Mandeep Mudhar, Head of Alphega Pharmacy UK, sat down with Boo Dhaliwal from Pharmacy Planet to discuss the importance of community pharmacy, leadership, strategy and more.  

 

Mandeep highlights opportunities in prescribing, NHS services, and wellness, while showcasing Alphega’s support through mentoring, compliance, and strategic guidance for pharmacy growth. The discussion also explores the challenges faced by independent community pharmacies today.

 

 Boo Dhaliwal and Mandeep Mudhar

 

The conversation covers:

 

• Mandeep’s journey from academia to pharmacy leadership  

• The shift from dispensing-focused pharmacies to service-led care

• The operational challenges facing independent contractors  

• How pharmacies can improve efficiency and category growth  

• The future of independent prescribing and NHS services  

• OTC, wellness, and supplement opportunities in pharmacy  

• How Alphega supports pharmacies with mentoring and compliance

 

Watch the full video here: Pharmacy Leadership: From Academia to the Frontline – Mandeep Mudhar’s Journey - YouTube  

SUB-TYPE:

SUB-TYPE: CLASS 2 RECALL

Class 2 recall-Human normal Immunoglobulin 500IU solution for Injection

Bio Products Laboratory Limited is recalling one batch of Human Rabies Immunoglobulin following a stability failure for this batch. The batch has shown a reduction in potency of the Human Rabies immunoglobulin.

 

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-bio-products-laboratory-limited-rabies-human-normal-immunoglobulin-500iu-solution-for-injection-el-26-a-slash-18

 

MHRA drug alert date:30/03/26

 

Pip code

Product description

Supplier

Batch Numbers

Alliance do not stock

Rabies, Human normal Immunoglobulin 500IU solution for Injection

Bio Products Laboratory Limited

JRC24208

 

 

Further Information

For all medical information enquiries and information on this product, please email medinfo@bpl.co.uk  or medinfo@kedrion.com or telephone +44 (0)20 89572255, +44 (0)20 89572622 or +44 (0)20 89572200

For stock control enquiries please email bplorders@kedrion.com, or telephone +44 (0)20 89572251

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 caution in use-Apixaban 2.5mg and 5mg Tablets

Sandoz Ltd. have informed the MHRA that the Patient Information Leaflet included in specified batches of Apixaban does not contain up‑to‑date information.

 

MHRA drug alert Date: 26/3/26

 

MHRA drug alert link:Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2.5mg and 5mg Tablets, EL(26)A/17 - GOV.UK

 

 

Pip code

Product description

Supplier

Batch Numbers

1258888

Apixaban 5mg Tablets (56)

Sandoz Limited

PS2891

PT0565

PT1417

PU0476

PU0481

1258870

Apixaban 5mg Tablets (28)

 

Sandoz Limited

PV5375

PW1623

PW1624

1258896

Apixaban 2.5mg Tablets (10)

Sandoz Limited

PT1722

1258904

Apixaban 2.5mg Tablets (20)

Sandoz Limited

PU3287

 

1258862

Apixaban 2.5mg Tablets (60)

Sandoz Limited

PU1963

PT4596

PT2868

PU2604

PU2605

PU2606

 

 

This is a caution in use only we are not accepting stock returns

 

Further Information

 

For all medical information enquiries and information on this product, please email mi.uk@sandoz.com, or telephone +44 1276 698101.

For stock control enquiries please email sales.sandoz-gb@sandoz.com, or telephone +44 1276 698020.

 

 

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 caution in use- PI Vesomni 6 mg/0.4 mg modified release tablets

Quadrant Pharmaceuticals Limited have informed the MHRA that their parallel imported packs of Vesomni 6 mg/0.4 mg modified release tablets have been printed with the incorrect barcode/GTIN on the carton.

 

MHRA drug alert Date: 26/3/26

 

MHRA drug alert link:Class 4 Medicines Defect Notification: Quadrant Pharmaceuticals Limited, Vesomni 6 mg/0.4 mg modified release tablets , EL(26)A/16 - GOV.UK

 

pip code

Product description

Supplier

Batch Numbers

8414435

PI VESOMNI TABS 6+0.4 MG

Quadrant Pharmaceuticals Limited

4097Y
4105Y
4322Y
5386Y
7330Y
7347Y

 

 

This is a caution in use only we are not accepting stock returns

 

Further Information

 

For all medical information enquiries and information on this product, please email maxearnqa@maxearn.co.uk or telephone 01204 471269.

For stock control enquiries please email maxearnqa@maxearn.co.uk or telephone 01204 471269.

SUB-TYPE: CLASS 2 RECALL

Class 2 recall-Hibiwash 500ml

Mölnlycke Health Care are recalling specific batches of Hibiwash due to microbial contamination at the manufacturing facility, following routine weekly microbiological monitoring.

 

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-regent-medical-limited-slash-molnlycke-health-care-hibiwash-500ml-el-26-a-slash-15?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=090ab6cb-237a-4a04-a47b-b9e8dcf71bae&utm_content=immediately

 

MHRA drug alert date:23/03/26

 

Pip code

Product description

Supplier

Batch Numbers

4285383

HIBIWASH 4% 500ML

MOLNLYCKE HEALTHCARE

5156042
5156043
5156093

 

 

Further Information

For medical information enquiries please use contact: Vigilance@molnlycke.com or telephone: +46 31 722 30 00. For stock queries please contact: UK Responsible Person: mohammad.humadi@molnlycke.com  

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to